HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2019-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Eveliqure Biotechnologies GMBH
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00048 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance
- AUT
Notice details come from SAM.gov. Updated .
About this opportunity
Eveliqure Biotechnologies GmbH was awarded a cost-reimbursement plus fixed fee contract valued at $2,064,502 by the National Institute of Allergy and Infectious Diseases to support the advanced development of unspecified vaccine candidates for antibiotic resistant bacteria over an unspecified period of performance. This contract was awarded under the National Institutes of Health Broad Agency Announcement 2019-1 to support research area 003 for the development of vaccines targeting antibiotic resistant bacteria.
Notice text
Extent of Competition for award was through full and open competition. This award will be cost-reimbursement plus fixed fee. This type of contract has been selected because costs cannot be adequately defined at the time of contract award.
Awarded contract 75N93020C00048 to EVELIQURE BIOTECHNOLOGIES GMBH for 20645042.00 on 2020-08-27.
Notice history
| Notice | Type | Posted |
|---|---|---|
| HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | Award Notice | |
| This notice | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria | Award Notice | |
| 2019 NIAID Omnibus Broad Agency Announcement | Pre-Solicitation | |
| 2019 NIAID Omnibus Broad Agency Announcement | Special Notice |
6 of 11 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity